Published

13-10-2026

Barreiras estruturais e operacionais ao rastreamento, diagnóstico e manejo da hiperglicemia na gestação

Structural and Operational Barriers to the Screening, Diagnosis and Management of Hyperglycemia in Pregnancy

Barreras estructurales y operativas para el tamizaje, diagnóstico y manejo de la hiperglucemia en la gestación

DOI:

https://doi.org/10.15446/av.enferm.v44n2.125646

Keywords:

Barreiras ao Acesso aos Cuidados de Saúde, Hiperglicemia, Gravidez, Cuidado Pré-Natal, Saúde Pública (pt)
Barriers to Access of Health Services, Hyperglycemia, Pregnancy, Prenatal Care, Public Health (en)
Barreras de Acceso a los Servicios de Salud, Hiperglucemia, Embarazo, Atención Prenatal, Salud Pública (es)

Authors

Objetivo: Mapear as principais barreiras operacionais e estruturais relacionadas ao rastreamento, diagnóstico e manejo da hiperglicemia na gestação.

Síntese do conteúdo: Trata-se de uma revisão integrativa, cuja busca foi realizada nas bases PubMed, Scopus, LILACS, SciELO e BDENF em dois momentos: junho de 2024 e março de 2026. Incluíram-se estudos originais publicados em português, inglês ou espanhol entre 2014 e 2026. A seleção foi realizada por dois revisores independentes, com resolução de discordâncias por um terceiro. A amostra final incluiu 20 estudos de alta qualidade metodológica (MMAT ≥ 80%). Foram identificadas 13 barreiras operacionais, estruturais e logísticas ao longo da linha de cuidado. No rastreamento (3 barreiras), destacaramse a baixa adesão às diretrizes, o uso de protocolos seletivos e barreiras geográficas de acesso ao teste oral de tolerância à glicose (TOTG). No diagnóstico (5 barreiras), evidenciaram-se a ausência de consenso internacional e as limitações de custo-efetividade das abordagens em uma ou duas etapas. No manejo (5 barreiras), observou-se insuficiência de letramento em saúde, falta de suporte psicossocial e indisponibilidade de insumos para o automonitoramento glicêmico.

Conclusões: : As barreiras operacionais e estruturais identificadasdestacam o uso de protocolos restritivos, a falta de consenso diagnóstico e as limitações logísticas no manejo.

Objective: To map the main operational and structural barriers to screening, diagnosing, and managing hyperglycemia in pregnancy.

Content synthesis: This integrative review was conducted through searches in thePubMed, Scopus, LILACS, SciELO, and BDENF databases in two phases: June 2024and March 2026. We included original studies published in Portuguese, English,or Spanish between 2014 and 2026. Two independent reviewers selected studies,and a third resolved disagreements. The final sample included 20 studies with highmethodological quality (MMAT ≥ 80%). The reviewers identified 13 operational, structural, and logistical barriers along the care pathway. In screening (3 barriers),low adherence to guidelines, selective protocol use, and geographic barriers toaccessing the oral glucose tolerance test (OGTT) stood out. In diagnosis (5 barriers), we identified the lack of international consensus and cost- effectiveness limitationsof one- or two-step approaches. In management (5 barriers), we observed inadequate health literacy, limited psychosocial support, and a lack of supplies for blood glucose self-monitoring.


Conclusions: The identified operational and structural barriers highlight restrictive protocols, a lack of diagnostic consensus, and logistical limitations to management.

Objetivo: mapear las principales barreras operativas y estructurales relacionadas con el tamizaje, el diagnóstico y el manejo de la hiperglucemia durante la gestación.

Síntesis del contenido: se trata de una revisión integrativa, cuya búsqueda se realizó en las bases de datos PubMed, Scopus, LILACS, SciELO y BDENF en dos fases: junio de 2024 y marzo de 2026. Se incluyeron estudios originales publicados en portugués, inglés o español entre 2014 y 2026. La selección fue realizada por dos revisores independientes, con resolución de las discrepancias por un tercero. La muestra final incluyó 20 estudios de alta calidad metodológica (MMAT ≥ 80%). Se identificaron 13 barreras operativas, estructurales y logísticas a lo largo de la línea de cuidado. En el tamizaje (3 barreras), destacaron la baja adherencia a las directrices, el uso de protocolos selectivos y las barreras geográficas para acceder a la prueba de tolerancia oral a la glucosa (PTOG). En el diagnóstico (5 barreras), se evidenciaron la ausencia deconsenso internacional y las limitaciones en términos de costo-efectividad de los enfoques de una o dos etapas. En el manejo (5 barreras), se observaron la insuficiencia de la alfabetización en salud, la falta de apoyo psicosocial y la indisponibilidad de insumos para el automonitoreo glucémico.

Conclusiones: las barreras operativas y estructurales identificadas ponen de manifiesto el uso de protocolos restrictivos, la falta de consenso diagnóstico y las limitaciones logísticas en el manejo.

References

(1) Montenegro CAB; Rezende Filho J. Obstetrícia fundamental. 14. ed. Rio de Janeiro: Guanabara Koogan; 2017

(2) American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(1):S14-S31. https://pubmed.ncbi.nlm.nih.gov/31862745/

(3) Brasil. Ministério da Saúde. Organização Pan-Americana da Saúde (OPAS). Federação Brasileira das Associações de Ginecologia e Obstetrícia. Sociedade Brasileira de Diabetes. Tratamento do diabetes mellitus gestacional no Brasil. Brasília, OPAS, 2019. https://diabetes.org.br/wpcontent/uploads/2021/06/Consenso_Brasileiro_Manejo_DMG_2019.pdf

(4) Brasil. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas. Manual de gestação de alto risco. Brasília, 2022. https://atencaoprimaria.es.gov.br/Media/AtencaoPrimaria/Mulher/Manual%20Gesta%C3%A7%C3%A3o%20Alto%20Risco%202022.pdf

(5) Zajdenverg L; Dualib PM; Lauand TCG; Reichelt AJ; Satler F; Façanha CF; et al. Tratamento farmacológico do diabetes na gestação. Diretriz Oficial da Sociedade Brasileira de Diabetes (2026). https://diretriz.diabetes.org.br/tratamento-farmacologico-do-diabetes-na-gestacao/

(6) Almeida VLM; Alves VH; Rodrigues DP; Pereira AV; Vieira BDG; Santos IMM et al. O cuidado das enfermeiras no parto e no nascimento após a inserção do projeto Apice On. Av. Enferm. 2023;41(1):95068. http://doi.org/10.15446/av.enferm.v41n1.95068

(7) McIntyre HD; Catalano P; Zhang C; Desoye G; Mathiesen ER; Damm P. Gestational diabetes mellitus. Nat. Rev. Dis. Primers. 2019;5:47. https://doi.org/10.1038/s41572-019-0098-8

(8) Levesque JF; Harris MF; Russell G. Patient-centred access to health care: Conceptualizing access at the interface of health systems and populations. Int J Equity Health. 2013;12:18. https://doi.org/10.1186/1475-9276-12-18

(9) Thaddeus S; Maine D. Too far to walk: Maternal mortality in context. Soc Sci Med. 1994;38(8):1091-1110. https://doi.org/10.1016/0277-9536(94)90226-7

(10) Hinneh T; Jahn A; Agbozo F. Barriers to screening, diagnosis and management of hyperglycemia in pregnancy in Africa: A systematic review. Int Health. 2022;14(3):211-221. https://doi.org/10.1093/inthealth/ihab054

(11) Calancie L; Brown MO; Choi WA; Caouette JL; McCann J; Nam EY et al. Systematic review of interventions in early pregnancy among pregnant individuals at risk for hyperglycemia. Am J Obstet Gynecol MFM. 2025; 7(3):101606. https://doi.org/10.1016/j.ajogmf.2025.101606

(12) Phonyiam R. Barriers and facilitators to diabetes self-management in pregnant women with pre-existing type 2 diabetes mellitus: A scoping review. Curr Diabetes Rev. 2023; 19(6): e270622206400. https://doi.org/10.2174/1573399819666220627111430

(13) Tehrani FR; Naz MSG; Bidhendi-Yarandi R; Behboudi-Gandevani S. Effect of different types of diagnostic criteria for gestational diabetes mellitus on adverse neonatal outcomes: A systematic review, metaanalysis, and meta-regression. Diabetes Metab J. 2022; 46(4): 605-619. https://doi.org/10.4093/dmj.2021.0178

(14) Mendes KDS; Silveira RCCP; Galvão CM. Uso de gerenciador de referências bibliográficas na seleção de estudos primários em revisão integrativa. Texto Contexto Enferm. 2019;28:e20170204. https://doi.org/10.1590/1980-265X-TCE-2017-0204

(15) Hong QN; Fàbregues S; Bartlett G; Boardman F; Cargo M; Dagenais P et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018;34(4):285- 291. https://doi.org/10.3233/EFI-180221

(16) Imoh LC; Longwap AS; Haruna FE; Asieba OJ; Istifanus JP; Imoh JA et al. Practices and barriers to screening for hyperglycaemia in pregnancy among providers of antenatal care in Jos, Nigeria. Afr J Lab Med. 2022;11(1):1845. https://doi.org/10.4102/ajlm.v11i1.1845

(17) Mukuve A; Noorani M; Sendagire I; Mgonja M. Magnitude of screening for gestational diabetes mellitus in an urban setting in Tanzania: a cross-sectional analytic study. BMC Pregnancy Childbirth. 2020;20:418. https://doi.org/10.1186/s12884-020-03115-3

(18) Abindu V; Hope D; Aleni M; Andru M; Ayiasi RM; Afayo V et al. Missed diagnosis of gestational diabetes mellitus due to selective screening: Evidence from a cross-sectional study in the West Nile sub-region, Uganda. Diabetes Metab Syndr Obes. 2024;17:1309-1319. https://doi.org/10.2147/DMSO.S447855

(19) Van Hoorn F; Koster MPH; Naaktgeboren CA; Groenendaal F; Kwee A; Lamain-de Ruiter M et al. Prognostic models versus single risk factor approach in first-trimester selective screening for gestational diabetes mellitus: A prospective population-based multicentre cohort study. BJOG. 2021;128(4):645-654.

https://doi.org/10.1111/1471-0528.16446

(20) Nwali SA; Onoh RC; Dimejesi IB; Obi VO; Jombo SE; Edenya OO. Universal versus selective screening for gestational diabetes mellitus among antenatal clinic attendees in Abakaliki: Using the one-step 75 gram oral glucose tolerance test. BMC Pregnancy Childbirth. 2021;21:735. https://doi.org/10.1186/s12884-021-04168-8

(21) Kirke AB; Spry E; Atkinson D; Sinclair C; Marley JV. Oral glucose tolerance test—The imperfect gold standard for gestational diabetes screening: A qualitative study involving clinicians in regional, rural and remote areas of Western Australia. Health Promot J Austral. 2025;36(1):e899. https://doi.org/10.1002/hpja.899

(22) Kirke AB; Marley JV; Atkinson D; Spry EP; Sinclair C. Patient and contextual factors influence clinicians’ decision making regarding universal screening for gestational diabetes: Results of a factorial survey set in rural and remote Western Australia. BMC Pregnancy and Childbirth. 2025;25:1069. https://doi.org/10.1186/s12884-025-08225-4

(23) Leonco L; Kallel H; Nacher M; Thelusme L; Dueymes M; Mhiri R et al. Does universal screening for gestational diabetes mellitus improve neonatal outcomes in a socially vulnerable population: A prospective study in French Guiana. Front Endocrinol. 2021;12:644770. https://doi.org/10.3389/fendo.2021.644770

(24) Nunes RD; Flôres ME; Seemann M; Traebert E; Traebert J. Two criteria of oral glucose tolerance test to diagnose gestational diabetes mellitus. Rev Assoc Med Bras. 2020;66(2):139-145. https://doi.org/10.1590/1806-9282.66.2.139

(25) Kim MH; Kwak SH; Kim SH; Hong JS; Chung HR; Choi SH et al. Pregnancy Outcomes of Women Additionally Diagnosed as Gestational Diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria. Diabetes Metab J. 2019;43(6):766-775. https://doi.org/10.4093/dmj.2018.0192

(26) Todi S; Sagili H; Kamalanathan SK. Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG ) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus. Arch Gynecol Obstet. 2020;302:47-52. https://doi.org/10.1007/s00404-020-05564-9

(27) O'Malley EG; Reynolds CME; O'Kelly R; McMahon L; Sheehan SR; Turner MJ. The diagnosis of gestational diabetes mellitus (GD M) using a 75 g oral glucose tolerance test: A prospective observational study. Diabetes Res Clin Pract. 2020;163:108144. https://doi.org/10.1016/j.diabres.2020.108144

(28) Jones DL; Kusinski LC; Barker P; Burling K; Halsall I; Turner E et al. Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes. Diabet Med. 2025;42(3):e15476. https://doi.org/10.1111/dme.15476

(29) Goyette F; Wo BL; Iglesias MH; Rey E; Godbout A. Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes. Diabetes Metab. 2023;49(4):101458. https://doi.org/10.1016/j.diabet.2023.101458

(30) Tehrani FR; Rahmati M; Farzadfar F; Abedini M; Farahmand M; Hosseinpanah F et al. One-step versus two-step screening for diagnosis of gestational diabetes mellitus in Iranian population: A randomized community trial. Front Endocrinol. 2023;13:e1039643. https://doi.org/10.3389/fendo.2022.1039643

(31) Immanuel J; Kongbrailatpam T; Rajagopal R; Simmons D. Evaluation of the analytical and clinical accuracy of four blood glucose meters in pregnant women with hyperglycaemia. Diabetes Obes Metab. 2025;27(4):2131-2137. https://doi.org/10.1111/dom.16209

(32) Sun S; Chen C; Qian S; Cai Y. Efeito da intervenção de enfermagem com objetivos diversificados no período perinatal de pacientes com diabetes mellitus gestacional. Acta Paul Enferm. 2024;37:eAPE01773. http://dx.doi.org/10.37689/acta-ape/2024AO00001773

(33) Fathnezhad-Kazemi A; Seifinadergoli Z; Ahmadi M. Factors affecting the quality of life in pregnant women with diabetes: The mediating effect of illnesses acceptance. BMC Pregnancy and Childbirth. 2024;24:513. https://doi.org/10.1186/s12884-024-06690-x

(34) Bernasko J. A framework to classify gestational diabetes diagnosed by routine antenatal 75g glucose tolerance testing. J. Matern Fetal Neonatal Med. 2024; 37(1):2373393. https://doi.org/10.1080/14767058.2024.2373393

(35) Tian Y; Zhang S; Huang F; Shi F; Li Y; Chen X et al. Glycemic qualification rate and frequency of self-monitoring blood glucose glycemic qualification rate and frequency of self-monitoring blood glucose (SMBG) in women with gestational diabetes mellitus (GD M). Diabetes Res Clin Pract. 2020;170:108482. https://doi.org/10.1016/j.diabres.2020.108482

(36) Farrar D; Simmonds M; Bryant M; Lawlor DA; Dunne F; Tuffnell D et al. Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts. PLoS ONE. 2017;12(4):e0175288. https://doi.org/10.1371/journal.pone.0175288

(37) Bogdanet D; O'Shea P; Lyons C; Shafat A; Dunne F. The oral glucose tolerance test —Is it time for a change? —A literature review with an emphasis on pregnancy. J Clin Med. 2020;9(11):3451. https://doi.org/10.3390/jcm9113451

(38) Moon JH; Jang HC. Gestational diabetes mellitus: Diagnostic approaches and maternal-offspring complications. Diabetes Metab J. 2022;46(1):3-14. https://doi.org/10.4093/dmj.2021.0335

(39) Nicolosi BF; Vernini JM; Costa RA; Magalhães CG; Rudge MVC; Corrente JE et al. Maternal factors associated with hyperglycemia in pregnancy and perinatal outcomes: a Brazilian reference center cohort study. Diabetol Metab Syndr. 2020; 12:49. https://doi.org/10.1186/s13098-020-00556-w

(40) Brasil. Ministério da Saúde. Organização Pan-Americana da Saúde. Federação Brasileira das Associações de Ginecologia e Obstetrícia. Sociedade Brasileira de Diabetes. Cuidados obstétricos em diabetes mellitus gestacional no Brasil. Brasília, 2021. https://portaldeboaspraticas.iff.fiocruz.br/wp-content/uploads/2022/05/ livro_cuidados_obstetricos.pdf

(41) Salis S; Vora N; Syed S; Ram U; Mohan V. Management of gestational diabetes mellitus with medical nutrition therapy. J Diabetol. 2021;12:S52-S58. https://doi.org/10.4103/jod.jod_44_21

(42) McLean A; Sinha A; Barr E; Maple-Brown L. Feasibility and acceptability of intermittently scanned continuous glucose monitoring for women with type 2 diabetes in pregnancy. J Diabetes Sci Technol. 2023;17(1):256–258. https://doi.org/10.1177/19322968221124956

(43) Saha S. Compliance and barriers to self-monitoring of blood glucose in patients with gestational diabetes mellitus: A systematic review. Int J of Health Sci. 2019;13(3):44-52.

https://pubmed.ncbi.nlm.nih.gov/31123440/

(44) Song Y; Zhai X; Bai Y; Liu C; Zhang L. Progress and indication for use of continuous glucose monitoring in patients with diabetes in pregnancy: A review. Front Endocrinol. 2023;14:1218602. https://doi.org/10.3389/fendo.2023.1218602

(45) República Federativa do Brasil. Portaria No 2.583, de 10 de outubro de 2007. Define o elenco de medicamentos e insumos que devem ser disponibilizados na rede do Sistema Único de Saúde, destinados ao monitoramento da glicemia capilar dos portadores de diabetes mellitus, nos termos da Lei nº. 11.347, de 27 de setembro de 2006. Diário Oficial da União 2007. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2007/prt2583_10_10_2007.html

(46) McIntyre HD; Catalano P; Zhang C; Desoye G; Mathiesen ER; Damm P. Gestational diabetes mellitus. Nat Rev Dis Prim. 2019;5:47. https://doi.org/10.1038/s41572-019-0098-8

(47) Hod M; Kapur A; Sacks DA; Hadar E; Agarwal M; Di Renzo GC et al. The International Federation of Gynecology and Obstetrics (FIGO ) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131(3):S173-S211. https://doi.org/10.1016/S0020-7292(15)30033-3

(48) República Federativa do Brasil. Ministério da Saúde. Política Nacional de Atenção Integral à Saúde da Mulher. Brasília: Ministério da Saúde, 2004. https://bvsms.saude.gov.br/bvs/publicacoes/politica_nac_atencao_mulher.pdf

(49) República Federativa do Brasil. Portaria GM/MS n.º 5.350, de 12 de setembro de 2024. Altera a Portaria de Consolidação GM/MS n.º3, de 28 de setembro de 2017, para dispor sobre a Rede Alyne. Diário Oficial da União 2024. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2024/prt5350_13_09_2024.html

(50) World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Genebra, 2016. https://iris.who.int/bitstream/handle/10665/250796/9789241549912-eng.pdf?sequence=1

(51) National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. London: NICE; 2020. https://www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-from-pr econception-to-thepostnatal-period-pdf-51038446021

(52) Institute for Health Metrics and Evaluation. GBD 2021 DI ABETES COLLABORATORS . Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023; 402(10397):203-234. https://doi.org/10.1016/S0140-6736(23)01301-6

(53) Nações Unidas Brasil. Agenda 2030 para o Desenvolvimento Sustentável. Brasília: Nações Unidas no Brasil. https://brasil.un.org/pt-br/91863-agenda-2030-para-o-desenvolvimento-sustent%C3%A1vel

Dimensions

PlumX

Article abstract page views

2

Downloads

Download data is not yet available.

How to Cite

1.
Santos MRN, Santos AM, Granado FS, da Silva MR, Silva JCN, Silva D de O, et al. Structural and Operational Barriers to the Screening, Diagnosis and Management of Hyperglycemia in Pregnancy. Av. enferm. [Internet]. 2026 Oct. 13 [cited 2026 Nov. 15];44(2):125646. Available from: https://revistas.unal.edu.co/index.php/avenferm/article/view/125646